New Measures to Report Medicine Disappearances
Recommendation

Tuesday, 6 October 2026 9 .30 - 16.45 h
According to a press release from EDQM, Strasbourg, dated 04 July 2024, the Recommendation CM/Rec(2024)3 of the Committee of Ministers to member States on reporting of disappearances of medicinal products for human and veterinary use from the legal supply chain was adopted by the Council of Europe Committee of Ministers on 10 April 2024.
"The recommendation calls for member states to create and deploy suitable frameworks and systems for reporting, information sharing, and data collection, preferably under the guidance of the national competent authority for medicines. The recommendation further emphasizes the need for cooperation: addressing and preventing disappearances of medicines cannot be successful if not addressed in cooperation with law enforcement authorities and other stakeholders."
Background
In the past decade, Europe has witnessed numerous cases where medicines have disappeared from the legal supply chain, been tampered with, and reintroduced, posing significant risks to public health. These incidents often go unreported to health regulatory authorities because theft is considered a criminal matter and reported only to law enforcement. Fragmented reporting and lack of centralized data collection have led to an underestimation of the problem's scale.
For more details, please see the EDQM press release and Recommendation CM/Rec(2024)3.
Related GMP News
10.09.2026European GDP Association Developments May through August 2026
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations


